Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability.

Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A. · 2019

Read Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. by Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6510537.txt.

Introduction

Sullivan and co-authors measure nutrient levels inside mouse tumours. Their study appeared in eLife. Cancer metabolism depends on what nutrients reach tumour cells. Blood plasma levels may not match levels in the fluid around those cells.

The team used quantitative metabolomics on plasma and tumour interstitial fluid. They measured absolute concentrations of more than 118 metabolites. Samples came from mouse models of pancreatic and lung adenocarcinoma. Nutrient levels in tumour fluid differed from levels in circulation. The authors also compared tumour types and transplant models. Tumour type, body location and animal diet all shaped local nutrient supply. The data form a reference for work on tumour metabolism.

Catalog record

CREATORSullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE94 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6510537

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability By Mark R Sullivan, Laura V Danai, Caroline A Lewis, Sze Ham Chan, Dan Y Gui, Tenzin Kunchok, Emily A Dennstedt, Matthew G Vander Heiden, Alexander Muir, Ralph DeBerardinis, Maarten van Lohuizen Published in: eLife DOI: 10.7554/eLife.44235 ABSTRACT Cancer cell metabolism is heavily influenced by microenvironmental factors, including nutrient availability. Therefore, knowledge of microenvironmental nutrient levels is essential to understand tumor metabolism. To measure the extracellular nutrient levels available to tumors, we utilized quantitative metabolomics methods to measure the absolute concentrations of >118 metabolites in plasma and tumor interstitial fluid, the extracellular fluid that perfuses tumors. Comparison of nutrient levels in tumor interstitial fluid and plasma revealed that the nutrients available to tumors differ from those present in circulation. Further, by comparing interstitial fluid nutrient levels between autochthonous and transplant models of murine pancreatic and lung adenocarcinoma, we found that tumor type, anatomical location and animal diet affect local nutrient availability. These data provide a comprehensive characterization of the nutrients present in the tumor microenvironment of widely used models of lung and pancreatic cancer and identify factors that influence metabolite levels in tumors. INTRODUCTION Tumors exhibit altered metabolism compared to non-transformed tissues (DeBerardinis and Chandel, 2016). For example, animal limbs transformed with oncogenic viruses exhibit increased glucose uptake and lactate secretion relative to unaffected limbs (Cori and Cori, 1925). Some aspects of tumor metabolism, including higher rates of glucose fermentation to lactate, are cell-intrinsic features that are retained when cancer cells are isolated from tumors (Koppenol et al., 2011). Indeed, numerous studies have delineated how cell-intrinsic factors such as oncogenic lesions or epigenetic state alter cellular metabolism, causing phenotypes such as increased glycolysis (Nagarajan et al., 2016). However, beyond cell-intrinsic alterations, tumors have modified tissue architecture and an altered tissue microenvironment; these cell-extrinsic factors can also impact the metabolism of tumors (Muir et al., 2018). For instance, the metabolic utilization of both glucose and the amino acid glutamine differs between cells growing in culture and murine tumor models (Davidson et al., 2016; Muir et al., 2017; Sellers et al., 2015; Tardito et al., 2015). Further, the metabolic enzymes that cancer cells rely upon for proliferation in culture are different than those that the same cells utilize to support growth and survival in tumors (Alvarez et al., 2017; Possemato et al., 2011; Yau et al., 2017). Thus, cancer cell metabolism is influenced by microenvironmental cues. Numerous microenvironmental factors affect cancer cell metabolism (Anastasiou, 2017; Bi et al., 2018; Muir et al., 2018; Wolpaw and Dang, 2018), including the presence of stromal cells (Lyssiotis and Kimmelman, 2017; Morandi et al., 2016), tumor acidity (Corbet and Feron, 2017; Persi et al., 2018), extracellular matrix properties (DelNero et al., 2018; Tung et al., 2015) and tumor nutrient levels (Muir and Vander Heiden, 2018). In particular, environmental nutrient availability is an important regulator of cancer cell metabolism (Cantor et al., 2017; Muir et al., 2017; Schug et al., 2015; Tardito et al., 2015). Nutrient differences between standard cell culture and animal tumor models can drive substantial changes in cancer cell metabolism that alter the response of cancer cells to metabolically targeted drugs (Cantor et al., 2017; Gui et al., 2016; Muir et al., 2017; Palm et al., 2015), such that drugs that inhibit proliferation of cancer cells in culture fail to exhibit efficacy in tumors derived from the same cells (Biancur et al., 2017; Davidson et al., 2016). Thus, determining the concentrations of nutrients in the tumor microenvironment is important to understand and therapeutically target cancer cell metabolism. Tumors and tissues are supplied with nutrients through the vasculature, which filters a nutrient rich fluid from the circulation into the interstitial space of a tissue or tumor (Wiig and Swartz, 2012). The interstitial fluid (IF) then perfuses through the tissue or tumor, exchanging nutrients and wastes with cells. IF is then drained from the tissue or tumor via capillaries and the lymphatic system. Thus, cells in tissues or tumors are not necessarily directly exposed to the nutrients in circulating plasma, but instead are exposed to IF nutrient levels. For healthy organs, IF nutrient levels may be similar to circulating nutrient levels, as these tissues are well vascularized, allowing rapid metabolic exchange with the plasma. Indeed, the IF glucose concentration in healthy skin is very similar to that of circulating plasma (Lönnroth et al., 1987). In contrast to the functional vessels found in normal tissues, tumors commonly have an abnormal vasculature with few vessels transporting blood (Fukumura et al., 2010). This may lead to reduced nutrient delivery and waste exchange between tumor cells and the circulation. Thus, tumor interstitial fluid (TIF) is thought to be nutrient depleted compared to either normal tissues or the circulation, and have increased concentrations of metabolic waste products. Indeed glucose levels in the TIF of some tumors are lower than in the circulation, while lactate levels are higher (Burgess and Sylven, 1962; Gullino et al., 1964; Ho et al., 2015). However, despite the importance of nutrient availability in regulating tumor metabolism and drug sensitivity, TIF nutrients beyond glucose and lactate have not been comprehensively measured, and the factors that determine TIF composition have not been characterized. We sought to systematically measure absolute nutrient concentrations in plasma and TIF. To do so, we have utilized a quantitative mass spectrometry-based approach using both external standards and stable isotope dilution of a library of carbon labeled metabolites to determine the concentration of >118 nutrients in biological fluids. We applied this technique to measure nutrient levels in plasma and TIF isolated from autochthonous and transplantation models of murine lung (LUAD) and pancreatic adenocarcinomas (PDAC) driven by activation of Kras and deletion of p53. Interestingly, we found that anatomical location and tumor tissue of origin are both major determinants of TIF nutrient composition. Dietary changes are also reflected in TIF nutrient levels, while introduction of a Keap1 mutation into LUAD cells had a smaller effect on the composition of the metabolic tumor microenvironment. Collectively, these experiments elucidate the microenvironmental constraints placed upon tumor metabolism by TIF nutrient levels and provide insight into the factors that dictate tumor nutrient availability. RESULTS Isolation of TIF from murine PDAC tumors We first focused on isolating and analyzing TIF nutrient levels in pancreatic ductal adenocarcinoma (PDAC), as this tumor type is known to have inadequate vasculature leading to tumor hypoxia (Koong et al., 2000) and nutrient deprivation (Commisso et al., 2013; Kamphorst et al., 2015; Lyssiotis and Kimmelman, 2017; Sherman et al., 2017; Sousa et al., 2016). End-stage tumors were isolated from the LSL-KrasG12D/+; Trp53flox/flox; Pdx-1-Cre, (KP-/-C) mouse model of PDAC (Bardeesy et al., 2006). This mouse model recapitulates many aspects of the human disease including dense stroma (Bardeesy et al., 2006) and alterations in systemic metabolism (Danai et al., 2018; Mayers et al., 2014). We applied a previously described method to collect TIF; tumors were placed on a fine mesh and subjected to low speed centrifugation (Figure 1A) (Haslene-Hox et al., 2011). This method has previously been used to study glucose and lactate levels in tumor samples (Ho et al., 2015; Siska et al., 2017). [Figure: Stable Isotope dilution can be utilized to analyze the composition of

Read the complete text